Sidmak

Valsad, India Founded: 1983 • Age: 43 yrs
Develops and manufactures pharmaceutical compositions
Annual revenue $8.7M Latest available
Total funding $2.9M 2 rounds
Employees 402 Tracked headcount
Investors 4 Known backers
Products - Services tracked
Competitors - Brand Intelligence

About Sidmak

Sidmak is a company based in Valsad (India) founded in 1983. Sidmak has raised $2.89 million across 2 funding rounds from investors including Sun Pharma, Mackinonenterprise and Shanghavi Finance. The company has 402 employees as of April 07, 2024.

  • Headquarter Valsad, India
  • Employees 402 as on 07 Apr, 2024
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Legal Name Sidmak Laboratories (India) Private Limited
  • Date of Incorporation 06 May, 1983
  • Jurisdiction Valsad, Gujarat, India
Operational Areas
Healthcare → Pharmaceuticals & Therapeutics Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $8.69 M (USD)
    -13.02
    as on Mar 31, 2023
  • Net Profit
    -$262.41 K (USD)
    -261.45
    as on Mar 31, 2023
  • EBITDA
    $185.48 K (USD)
    -74.6
    as on Mar 31, 2023
  • Total Equity Funding
    $2.89 M (USD)

    in 2 rounds

  • Latest Funding Round
    $1.9 M (USD), Unspecified

    Oct 30, 2024

  • Investors
    Sun Pharma

    & 3 more

  • Employee Count
    402

    as on Apr 07, 2024

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Sidmak

Sidmak has successfully raised a total of $2.89M across 2 strategic funding rounds. The most recent funding activity was a Unspecified round of $1.9 million completed in October 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

Investors in Sidmak

Sidmak has secured backing from 4 investors, including institutional investors. Prominent investors backing the company include Sun Pharma, Mackinonenterprise and Shanghavi Finance.

All
Institutional
Investor Description Founded Year Domain Location
Specialty generic pharmaceuticals and APIs are manufactured and marketed.
Locked Locked Locked
-
Locked Locked Locked
-
Locked Locked Locked
Premium access

Investor details for Sidmak

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Sidmak

Investments
Premium access

Investment portfolio details for Sidmak

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Sidmak

Premium access

Detailed financials for Sidmak

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Sidmak Comparisons

Sidmak Primary company
Description
Develops and manufactures pharmaceutical compositions
Location
Valsad, India
Founded Year
1983
Annual Revenue
$8.69 M (USD)
Net Profit
-$262.41 K (USD)
EBITDA
$185.48 K (USD)
Employees
402
As of 2024
Premium access

Peer comparison for Sidmak

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Sidmak

Premium access

Detailed competitors of Sidmak

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Sidmak

Premium access

Complete news archive for Sidmak

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sidmak

Sidmak was founded in 1983 and raised its 1st funding round 27 years after it was founded.

Sidmak is headquartered in Valsad, India. It is registered at Valsad, Gujarat, India.

Sidmak is a funded company, having raised a total of $2.89M across 2 funding rounds to date.

As of Apr 07, 2024, the latest employee count at Sidmak is 402.

Annual revenue of Sidmak is $8.69M as on Mar 31, 2023.

Sidmak was founded in 1983 and is based in Valsad, India, within the pharmaceuticals sector. Operations focus on the development and manufacture of compositions, particularly those involving cyclosporine for immunosuppressive uses and anticancer formulations for oncology applications. Various delivery systems and therapeutic indications are addressed through these activities, supporting global pharmaceutical needs.

Sidmak has 4 investors. Key investors include Sun Pharma, Mackinonenterprise, Shanghavi Finance, and nirmitexports.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available